Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Top 5 Healthcare Bets of World-Class Baker Bros. Advisors

Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker and Felix Baker in New York. Baker Bros. Advisors was the best performing hedge fund for the second quarter of 2015 among the over 700 funds covered by Insider Monkey, using our weighted average returns calculation methodology. The fund recently submitted its 13F with the Securities and Exchange Commission for the reporting period of September 30. The filing revealed that Baker Bros. Advisors’ U.S equity portfolio at the end of September was worth $10.8 billion and that capital was 100% invested in the healthcare sector. The filing also revealed that the top ten equity holdings of Baker Bros. Advisors accounted for almost 80% of the value of its equity portfolio. Since the fund invests most of its assets under management in its top equity picks, let’s closely analyze Baker Bros. Advisors’ top five healthcare stock picks going into the fourth quarter.

We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about six basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated 10 percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by 53 percentage points (102% return vs. the S&P 500’s 48.7% gain) over the last 38 months (see the details here).

#5 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

– Shares Owned by Baker Bros. Advisors (as of September 30): 20.48 Million

– Value of Holding (as of September 30): $677.32 Million

Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) have dropped by almost 30% from the highs they made in July. However, they are still trading up by more than 10% year-to-date. During the third quarter, Baker Bros. Advisors didn’t made any...